{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:16:18Z","timestamp":1785849378466,"version":"3.56.0"},"posted":{"date-parts":[[2025,10,17]]},"group-title":"Bioengineering","reference-count":81,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015326","name":"NIH Common Fund","doi-asserted-by":"crossref","award":["P30 AI045008"],"award-info":[{"award-number":["P30 AI045008"]}],"id":[{"id":"10.13039\/100015326","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100015326","name":"NIH Common Fund","doi-asserted-by":"crossref","award":["P30 CA016520"],"award-info":[{"award-number":["P30 CA016520"]}],"id":[{"id":"10.13039\/100015326","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100015326","name":"NIH Common Fund","doi-asserted-by":"crossref","award":["P30 CA016520"],"award-info":[{"award-number":["P30 CA016520"]}],"id":[{"id":"10.13039\/100015326","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100015326","name":"NIH Common Fund","doi-asserted-by":"crossref","award":["R01-AI136945-04"],"award-info":[{"award-number":["R01-AI136945-04"]}],"id":[{"id":"10.13039\/100015326","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000005","name":"United States Department of Defense","doi-asserted-by":"crossref","award":["HT94252510251"],"award-info":[{"award-number":["HT94252510251"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Breakthrough T1D","award":["3-SRA-2024-1612-S-B"],"award-info":[{"award-number":["3-SRA-2024-1612-S-B"]}]},{"name":"Tang Prize","award":["40143777"],"award-info":[{"award-number":["40143777"]}]},{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"crossref","award":["RNA Institute Pilot Award"],"award-info":[{"award-number":["RNA Institute Pilot Award"]}],"id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"crossref","award":["Roberts Family-Katalin KarikM-CM-3 Fellowship in Vaccine Research"],"award-info":[{"award-number":["Roberts Family-Katalin KarikM-CM-3 Fellowship in Vaccine Research"]}],"id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,10,17]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:p>\n                  The modularity of mRNA-lipid nanoparticle (mRNA-LNP) platforms has enabled their rapid adaptation from infectious disease vaccines to emerging applications in immune-mediated disorders. However, extending mRNA-LNPs to autoimmune and inflammatory diseases requires precise control over immune cell targeting and immunogenicity. Here, we systematically investigate how incorporating anionic lipids into LNPs modulates both immune cell tropism and innate immune activation. Using a library of 40 distinct LNP formulations, we demonstrate that anionic lipids enhance mRNA delivery to splenic dendritic cells, reduce early cellular markers of adjuvant activity and tune cytokine responses in a lipid-dependent manner. We identify formulations that retain pro-inflammatory adjuvant activity and others that promote tolerogenic responses. A lead formulation containing the anionic lipid DOPG selectively dampens innate activation and induces IL-10 production. When encoding the myelin antigen MOG\n                  <jats:sub>35-55<\/jats:sub>\n                  , this LNP suppresses disease in a mouse model of multiple sclerosis, reducing neuroinflammation, T cell infiltration, and maintaining myelin morphology. These findings establish a framework for designing immune-targeted mRNA\u2013LNPs with tunable immunogenicity and promote the development of antigen-specific tolerizing immunotherapies for autoimmune disease.\n                <\/jats:p>","DOI":"10.1101\/2025.10.17.683125","type":"posted-content","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T03:10:15Z","timestamp":1760757015000},"source":"Crossref","is-referenced-by-count":5,"title":["Anionic lipids modulate mRNA-lipid nanoparticle immunogenicity and confer protection in a mouse model of multiple sclerosis"],"prefix":"10.64898","author":[{"given":"Jilian R.","family":"Melamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Muscat-Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley S.","family":"Chaboub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxanne","family":"Perez-Tremble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navdeep S.","family":"Bhalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houping","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew","family":"Weissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2025102203500400000_2025.10.17.683125v1.1","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0247-3"},{"key":"2025102203500400000_2025.10.17.683125v1.2","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-023-01404-4"},{"key":"2025102203500400000_2025.10.17.683125v1.3","doi-asserted-by":"crossref","unstructured":"Hajj, K. A. & Whitehead, K. A . Tools for translation: non-viral materials for therapeutic mRNA delivery. Nat Rev Mater 2, 17056 (2017).","DOI":"10.1038\/natrevmats.2017.56"},{"key":"2025102203500400000_2025.10.17.683125v1.4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05482-0"},{"key":"2025102203500400000_2025.10.17.683125v1.5","doi-asserted-by":"crossref","unstructured":"Ackun-Farmmer, M. A. & Jewell, C. M . Delivery Route Considerations for Designing Antigen-Specific Biomaterial Strategies to Combat Autoimmunity. Advanced NanoBiomed Research 3, 2200135 (2023).","DOI":"10.1002\/anbr.202200135"},{"key":"2025102203500400000_2025.10.17.683125v1.6","doi-asserted-by":"publisher","DOI":"10.1126\/science.ade6967"},{"key":"2025102203500400000_2025.10.17.683125v1.7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32281-5"},{"key":"2025102203500400000_2025.10.17.683125v1.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2021.11.022"},{"key":"2025102203500400000_2025.10.17.683125v1.9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2207841119"},{"key":"2025102203500400000_2025.10.17.683125v1.10","doi-asserted-by":"crossref","unstructured":"Fenton, O. S. et al. Synthesis and Biological Evaluation of Ionizable Lipid Materials for the In Vivo Delivery of Messenger RNA to B Lymphocytes. Advanced Materials 29, 1606944 (2017).","DOI":"10.1002\/adma.201606944"},{"key":"2025102203500400000_2025.10.17.683125v1.11","doi-asserted-by":"crossref","unstructured":"Razavi, R. , Kegel, M. , Muscat-Rivera, J. , Weissman, D. & Melamed, J. R . Harnessing mRNA-lipid nanoparticles as innovative therapies for autoimmune diseases. Molecular Therapy Methods & Clinical Development 33, 101566 (2025).","DOI":"10.1016\/j.omtm.2025.101566"},{"key":"2025102203500400000_2025.10.17.683125v1.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2021.06.004"},{"key":"2025102203500400000_2025.10.17.683125v1.13","doi-asserted-by":"crossref","unstructured":"Rurik, J. G. , et al. CAR T cells produced in vivo to treat cardiac injury. (2022).","DOI":"10.1126\/science.abm0594"},{"key":"2025102203500400000_2025.10.17.683125v1.14","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202304378"},{"key":"2025102203500400000_2025.10.17.683125v1.15","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-020-0669-6"},{"key":"2025102203500400000_2025.10.17.683125v1.16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2109256118"},{"key":"2025102203500400000_2025.10.17.683125v1.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2022.03.046"},{"key":"2025102203500400000_2025.10.17.683125v1.18","doi-asserted-by":"crossref","first-page":"8304","DOI":"10.1021\/acs.nanolett.2c03234","article-title":"Phosphatidylserine Lipid Nanoparticles Promote Systemic RNA Delivery to Secondary Lymphoid Organs","volume":"22","year":"2022","journal-title":"Nano Lett"},{"key":"2025102203500400000_2025.10.17.683125v1.19","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202310395"},{"key":"2025102203500400000_2025.10.17.683125v1.20","doi-asserted-by":"publisher","DOI":"10.1038\/nature18300"},{"key":"2025102203500400000_2025.10.17.683125v1.21","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay3638"},{"key":"2025102203500400000_2025.10.17.683125v1.22","doi-asserted-by":"crossref","first-page":"e1629259","DOI":"10.1080\/2162402X.2019.1629259","article-title":"HPV16 RNA-LPX vaccine mediates complete regression of aggressively growing HPV-positive mouse tumors and establishes protective T cell memory","volume":"8","year":"2019","journal-title":"OncoImmunology"},{"key":"2025102203500400000_2025.10.17.683125v1.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2005.06.008"},{"key":"2025102203500400000_2025.10.17.683125v1.24","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2008.200"},{"key":"2025102203500400000_2025.10.17.683125v1.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2015.08.051"},{"key":"2025102203500400000_2025.10.17.683125v1.26","doi-asserted-by":"crossref","unstructured":"Sittplangkoon, C. et al. mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model. Front. Immunol. 13, 983000 (2022).","DOI":"10.3389\/fimmu.2022.983000"},{"key":"2025102203500400000_2025.10.17.683125v1.27","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20171450"},{"key":"2025102203500400000_2025.10.17.683125v1.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.11.001"},{"key":"2025102203500400000_2025.10.17.683125v1.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2021.12.027"},{"key":"2025102203500400000_2025.10.17.683125v1.30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035389"},{"key":"2025102203500400000_2025.10.17.683125v1.31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577"},{"key":"2025102203500400000_2025.10.17.683125v1.32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716153"},{"key":"2025102203500400000_2025.10.17.683125v1.33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2019.01.013","article-title":"Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines","volume":"15","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"2025102203500400000_2025.10.17.683125v1.34","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.1021\/acs.nanolett.0c00596","article-title":"A Potent Branched-Tail Lipid Nanoparticle Enables Multiplexed mRNA Delivery and Gene Editing In Vivo","volume":"20","year":"2020","journal-title":"Nano Lett"},{"key":"2025102203500400000_2025.10.17.683125v1.35","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201805097"},{"key":"2025102203500400000_2025.10.17.683125v1.36","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ade1444"},{"key":"2025102203500400000_2025.10.17.683125v1.37","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.12.1685"},{"key":"2025102203500400000_2025.10.17.683125v1.38","doi-asserted-by":"publisher","DOI":"10.1126\/science.1164206"},{"key":"2025102203500400000_2025.10.17.683125v1.39","doi-asserted-by":"crossref","first-page":"e20231282","DOI":"10.1084\/jem.20231282","article-title":"Site-specific regulation of Th2 differentiation within lymph node microenvironments","volume":"221","year":"2024","journal-title":"Journal of Experimental Medicine"},{"key":"2025102203500400000_2025.10.17.683125v1.40","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-024-01167-5"},{"key":"2025102203500400000_2025.10.17.683125v1.41","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.14.1.233"},{"key":"2025102203500400000_2025.10.17.683125v1.42","doi-asserted-by":"crossref","unstructured":"Maj, T. , Slawek, A. & Chelmonska-Soyta, A . CD80 and CD86 costimulatory molecules differentially regulate OT-II CD4+ T lymphocyte proliferation and cytokine response in cocultures with antigen-presenting cells derived from pregnant and pseudopregnant mice. Mediators Inflamm 2014, 769239 (2014).","DOI":"10.1155\/2014\/769239"},{"key":"2025102203500400000_2025.10.17.683125v1.43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1996.tb00921.x"},{"key":"2025102203500400000_2025.10.17.683125v1.44","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830260732"},{"key":"2025102203500400000_2025.10.17.683125v1.45","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.7.4331"},{"key":"2025102203500400000_2025.10.17.683125v1.46","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1900\/RDS.2012.9.348","article-title":"In vivo delivery of nucleic acid-formulated microparticles as a potential tolerogenic vaccine for type 1 diabetes","volume":"9","year":"2012","journal-title":"Rev Diabet Stud"},{"key":"2025102203500400000_2025.10.17.683125v1.47","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000489862","article-title":"Synergic Effects of CD40 and CD86 Silencing in Dendritic Cells on the Control of Allergic Diseases","volume":"177","year":"2018","journal-title":"Int Arch Allergy Immunol"},{"key":"2025102203500400000_2025.10.17.683125v1.48","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/gt.2014.119","article-title":"Permanent acceptance of mouse cardiac allografts with CD40 siRNA to induce regulatory myeloid cells by use of a novel polysaccharide siRNA delivery system","volume":"22","year":"2015","journal-title":"Gene Ther"},{"key":"2025102203500400000_2025.10.17.683125v1.49","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2011.01302.x"},{"key":"2025102203500400000_2025.10.17.683125v1.50","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01473-3"},{"key":"2025102203500400000_2025.10.17.683125v1.51","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70101-2"},{"key":"2025102203500400000_2025.10.17.683125v1.52","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03892-7"},{"key":"2025102203500400000_2025.10.17.683125v1.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2020.05.049"},{"key":"2025102203500400000_2025.10.17.683125v1.54","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830250723"},{"key":"2025102203500400000_2025.10.17.683125v1.55","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-009-9188-9"},{"key":"2025102203500400000_2025.10.17.683125v1.56","doi-asserted-by":"publisher","DOI":"10.1021\/nn405033r"},{"key":"2025102203500400000_2025.10.17.683125v1.57","doi-asserted-by":"crossref","unstructured":"Chen, N. et al. Co-Delivery of Disease Associated Peptide and Rapamycin via Acetalated Dextran Microparticles for Treatment of Multiple Sclerosis. Adv. Biosys. 1, 1700022 (2017).","DOI":"10.1002\/adbi.201700022"},{"key":"2025102203500400000_2025.10.17.683125v1.58","doi-asserted-by":"crossref","first-page":"eadd8693","DOI":"10.1126\/sciadv.add8693","article-title":"Bioengineered particles expand myelin-specific regulatory T cells and reverse autoreactivity in a mouse model of multiple sclerosis","volume":"9","year":"2023","journal-title":"Sci. Adv"},{"key":"2025102203500400000_2025.10.17.683125v1.59","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1120611109"},{"key":"2025102203500400000_2025.10.17.683125v1.60","doi-asserted-by":"crossref","first-page":"e2205417119","DOI":"10.1073\/pnas.2205417119","article-title":"Treatment with an antigen-specific dual microparticle system reverses advanced multiple sclerosis in mice","volume":"119","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"2025102203500400000_2025.10.17.683125v1.61","first-page":"828","article-title":"Treatment of Experimental Autoimmune Encephalomyelitis by Codelivery of Disease Associated Peptide and Dexamethasone in Acetalated Dextran Microparticles. Mol","volume":"11","year":"2014","journal-title":"Pharmaceutics"},{"key":"2025102203500400000_2025.10.17.683125v1.62","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1021\/acsbiomaterials.9b00332","article-title":"Dual-Sized Microparticle System for Generating Suppressive Dendritic Cells Prevents and Reverses Type 1 Diabetes in the Nonobese Diabetic Mouse Model","volume":"5","year":"2019","journal-title":"ACS Biomater Sci Eng"},{"key":"2025102203500400000_2025.10.17.683125v1.63","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.clim.2015.03.023","article-title":"A combination dual-sized microparticle system modulates dendritic cells and prevents type 1 diabetes in prediabetic NOD mice","volume":"160","year":"2015","journal-title":"Clinical Immunology"},{"key":"2025102203500400000_2025.10.17.683125v1.64","doi-asserted-by":"crossref","unstructured":"Chen, N. , Kroger, C. J. , Tisch, R. M. , Bachelder, E. M. & Ainslie, K. M . Prevention of Type 1 Diabetes with Acetalated Dextran Microparticles Containing Rapamycin and Pancreatic Peptide P31. Adv Healthcare Materials 7, 1800341 (2018).","DOI":"10.1002\/adhm.201800341"},{"key":"2025102203500400000_2025.10.17.683125v1.65","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20110574"},{"key":"2025102203500400000_2025.10.17.683125v1.66","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jaut.2017.12.010","article-title":"Tolerogenic Ag-PLG nanoparticles induce tregs to suppress activated diabetogenic CD4 and CD8 T cells","volume":"89","year":"2018","journal-title":"J Autoimmun"},{"key":"2025102203500400000_2025.10.17.683125v1.67","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1053\/j.gastro.2020.01.045","article-title":"Gliadin Nanoparticles Induce Immune Tolerance to Gliadin in Mouse Models of Celiac Disease","volume":"158","year":"2020","journal-title":"Gastroenterology"},{"key":"2025102203500400000_2025.10.17.683125v1.68","doi-asserted-by":"crossref","first-page":"e2304238","DOI":"10.1002\/adhm.202304238","article-title":"Autoantigen-Dexamethasone Conjugate-Loaded Liposomes Halt Arthritis Development in Mice","volume":"13","year":"2024","journal-title":"Adv Healthc Mater"},{"key":"2025102203500400000_2025.10.17.683125v1.69","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.3390\/pharmaceutics13111949","article-title":"Retinoic Acid-Containing Liposomes for the Induction of Antigen-Specific Regulatory T Cells as a Treatment for Autoimmune Diseases","volume":"13","year":"2021","journal-title":"Pharmaceutics"},{"key":"2025102203500400000_2025.10.17.683125v1.70","doi-asserted-by":"crossref","unstructured":"Thatte, A. S. , Billingsley, M. M. , Weissman, D. , Melamed, J. R. & Mitchell, M. J . Emerging strategies for nanomedicine in autoimmunity. Adv Drug Deliv Rev 207, 115194 (2024).","DOI":"10.1016\/j.addr.2024.115194"},{"key":"2025102203500400000_2025.10.17.683125v1.71","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.3390\/ph16091270","article-title":"Tolerogenic Lipid Nanoparticles for Delivering Self-Antigen mRNA for the Treatment of Experimental Autoimmune Encephalomyelitis","volume":"16","year":"2023","journal-title":"Pharmaceuticals (Basel"},{"key":"2025102203500400000_2025.10.17.683125v1.72","doi-asserted-by":"crossref","unstructured":"Benne, N. , Ter Braake, D. , Stoppelenburg, A. J. & Broere, F . Nanoparticles for Inducing Antigen-Specific T Cell Tolerance in Autoimmune Diseases. Front Immunol 13, 864403 (2022).","DOI":"10.3389\/fimmu.2022.864403"},{"key":"2025102203500400000_2025.10.17.683125v1.73","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707302"},{"key":"2025102203500400000_2025.10.17.683125v1.74","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.02.014"},{"key":"2025102203500400000_2025.10.17.683125v1.75","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/21691401.2019.1699812","article-title":"Preclinical evaluation of antigen-specific nanotherapy based on phosphatidylserine-liposomes for type 1 diabetes","volume":"48","year":"2020","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"2025102203500400000_2025.10.17.683125v1.76","doi-asserted-by":"crossref","unstructured":"Rodriguez-Fernandez, S. et al. Phosphatidylserine-Liposomes Promote Tolerogenic Features on Dendritic Cells in Human Type 1 Diabetes by Apoptotic Mimicry. Front Immunol 9, 253 (2018).","DOI":"10.3389\/fimmu.2018.00253"},{"key":"2025102203500400000_2025.10.17.683125v1.77","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2018.10.028","article-title":"Anionic 1,2-distearoyl-sn-glycero-3-phosphoglycerol (DSPG) liposomes induce antigen-specific regulatory T cells and prevent atherosclerosis in mice","volume":"291","year":"2018","journal-title":"J Control Release"},{"key":"2025102203500400000_2025.10.17.683125v1.78","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2012.7"},{"key":"2025102203500400000_2025.10.17.683125v1.79","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.omtn.2019.02.018","article-title":"A Facile Method for the Removal of dsRNA Contaminant from In Vitro-Transcribed mRNA","volume":"15","year":"2019","journal-title":"Molecular Therapy - Nucleic Acids"},{"key":"2025102203500400000_2025.10.17.683125v1.80","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-022-00755-x"},{"key":"2025102203500400000_2025.10.17.683125v1.81","doi-asserted-by":"publisher","DOI":"10.3791\/55226"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.10.17.683125","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T09:50:33Z","timestamp":1768470633000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2025.10.17.683125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":81,"URL":"https:\/\/doi.org\/10.1101\/2025.10.17.683125","relation":{},"subject":[],"published":{"date-parts":[[2025,10,17]]},"subtype":"preprint"}}